Literature DB >> 2335446

Effect of levodopa on contrast sensitivity and scotomas in human amblyopia.

I Gottlob1, E Stangler-Zuschrott.   

Abstract

The neurotransmitter dopamine (DA) is involved in several visual functions. Visual deprivation decreases retinal DA concentration in chickens and monkeys. In animals with deprivation amblyopia, several studies suggest that neurotransmitters are involved in visual-cortical plasticity and can restore partial visual acuity in adult cats. We investigated in a cross-over, double-masked study the influence of levodopa on contrast sensitivity and binocular suppression in human adult strabismic and amblyopic patients. After one single administration of levodopa, a significant increase in contrast sensitivity and decrease of the size of the fixation point scotoma was found. No changes could be detected after placebo administration. Levodopa did not induce changes in contrast sensitivity in the dominant eyes of the patients or in normal subjects. In conclusion, we found a short-term effect of levodopa on contrast sensitivity and fixation point scotomas in amblyopic eyes of adult patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335446

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

2.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

Review 3.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

4.  Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy.

Authors:  Deanna P Lyttle; Lenworth N Johnson; Edward A Margolin; Richard W Madsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-20       Impact factor: 3.117

Review 5.  Nuclear magnetic resonance spectroscopy. Principles and applications in neuroophthalmology.

Authors:  A Ettl; C Fischer-Klein; A Chemelli; A Daxer; S Felber
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

6.  Electro-oculographic abnormalities in amblyopia.

Authors:  C Williams; D Papakostopoulos
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

7.  Outcome of conventional treatment for adult amblyopia.

Authors:  Fumiko Kishimoto; Chiaki Fujii; Yoshie Shira; Kayoko Hasebe; Ichiro Hamasaki; Hiroshi Ohtsuki
Journal:  Jpn J Ophthalmol       Date:  2013-10-26       Impact factor: 2.447

8.  Visual information processing in recently abstaining methamphetamine-dependent individuals: evoked potentials study.

Authors:  Jan Kremlácek; Ladislav Hosák; Miroslav Kuba; Jan Libiger; Jirí Cízek
Journal:  Doc Ophthalmol       Date:  2008-06-19       Impact factor: 2.379

9.  Functional magnetic resonance imaging (fMRI) and effects of L-dopa on visual function in normal and amblyopic subjects.

Authors:  Gary L Rogers
Journal:  Trans Am Ophthalmol Soc       Date:  2003

10.  Visual acuities and scotomas after 3 weeks' levodopa administration in adult amblyopia.

Authors:  I Gottlob; S S Wizov; R D Reinecke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.